Tyra Biosciences Inc TYRA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/15/24 EDT
18.44quote price arrow down-0.14 (-0.75%)
Volume
127,862
52 week range
10.38 - 20.67
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close18.44
  • 52 Week High20.67
  • 52 Week High Date02/28/24
  • 52 Week Low10.38
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap968.54M
  • Shares Out52.52M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.08
  • YTD % Change33.14

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close18.44
  • 52 Week High20.67
  • 52 Week High Date02/28/24
  • 52 Week Low10.38
  • 52 Week Low Date10/27/23
  • Market Cap968.54M
  • Shares Out52.52M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.08
  • YTD % Change33.14

RATIOS/PROFITABILITY

  • EPS (TTM)-1.68
  • P/E (TTM)-10.94
  • Fwd P/E (NTM)-10.27
  • EBITDA (TTM)-87.509M
  • ROE (TTM)-23.63%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Tyra Biosciences Inc

 

Profile

MORE
Tyra Biosciences, Inc. is a clinical-stage biotechnology company. It is focused on developing precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. Its in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations to cause acquired resistance to existing therapies. Its initial focus is on applying its accelerated small molecule...
Robert More
Non-Executive Chairman of the Board
Todd Harris Ph.D.
President, Chief Executive Officer, Treasurer, Director
Daniel Bensen
Chief Operating Officer
Alan Fuhrman CPA
Chief Financial Officer
Ali Fawaz
General Counsel, Company Secretary
Address
2656 State Street
Carlsbad, CA
92008
United States

Top Peers

SYMBOLLASTCHG%CHG
VRDN
Viridian Therapeutics Inc
14.27-0.40-2.73%
ETNB
89Bio Inc
9.20+0.11+1.21%
SAVA
Cassava Sciences Inc
23.01-0.32-1.37%
SPRY
ARS Pharmaceuticals Inc
8.88-0.10-1.11%
ALXO
ALX Oncology Holdings Inc
15.02-0.15-0.99%